Denali Therapeutics, Inc. (DNLI)
16.95
+0.18
(+1.07%)
USD |
NASDAQ |
Dec 19, 14:55
Denali Therapeutics Shareholders Equity (Annual): 1.230B for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Novavax, Inc. | -623.84M |
| Agenus, Inc. | -326.38M |
| AIM ImmunoTech, Inc. | -1.322M |
| Protalix Biotherapeutics, Inc. | 43.21M |
| Armata Pharmaceuticals, Inc. | -48.02M |